Self-developed PharmAID Decision Intelligence Platform Integrates Global Leading Large Model Technology and Has connected ...

Co., Ltd. (Fosun Pharma; stock code: 600196.SH, 02196.HK) announced that its holding subsidiary, Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. ("Fosun Pharma Industrial"), has ...

Fosun Tourism Group ( (HK:1992)) has issued an announcement. Fosun Tourism Group announced the non-fulfillment of a pre-condition required for the potential share alternative option related to its ...

Shanghai Fosun Pharmaceutical announced that its holding subsidiary, Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. , has received approval from the National Medical Products ...

HONG KONG and SHANGHAI, Feb. 20, 2025 /PRNewswire/ -- Fosun's global operations achieved another milestone. On February 20, during the Abu Dhabi Investment Forum in Shanghai, Fosun International ...

Fosun International Limited (HKEX Stock Code: 00656, "Fosun International") was successfully selected into the yearbook for the second consecutive year for its continuous efforts in environmental ...

On 21 February, Guo Guangchang, Chairman of Fosun International spoke at the 25th Annual Conference of Yabuli China Entrepreneurs Forum 2025, stating that private enterprises are not afraid of ...

FOSUN PHARMA (02196.HK) recently released internally its self-developed PharmAID decision agent platform, which is currently constructing a full lifecycle intelligent decision-making network covering ...

As a global innovation-driven pharmaceutical and healthcare group, Fosun Pharma places great emphasis on the transformative potential of AI technology in the pharmaceutical and healthcare sectors.

Shanghai Fosun Pharmaceutical announced that its holding subsidiary, Shanghai Fosun Pharmaceutical Industrial Development Co.

On February 20, during the Abu Dhabi investment Forum in Shanghai, Fosun International signed a Memorandum of Strategic Cooperation with the Abu Dhabi Investment Office (ADIO). This collaboration aims ...